Construction of a Risk Model to Predict the Prognosis and Immunotherapy of Low-Grade Glioma Ground on 7 Ferroptosis-Related Genes

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas

(2022) Zijian Zhou et al.   Frontiers in Genetics

IDH1 mutations induce organelle defects via dysregulated phospholipids

(2021) Adrian Lita et al.   Nature Communications

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas

(2021) Yi Zheng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment

(2021) Renxuan Huang et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Ferroptosis in the tumor microenvironment: perspectives for immunotherapy

(2021) Huanji Xu et al.   TRENDS IN MOLECULAR MEDICINE

Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma

(2021) Chao Yang et al.   PeerJ

Mutational profiling of low‐grade gliomas identifies prognosis and immunotherapy‐related biomarkers and tumour immune microenvironment characteristics

(2021) Wen‐wen Lin et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Knock-down of LncRNA-XIST induced glioma cell death and inhibited tumorigenesis by regulating miR-137/SLC1A5 axis-mediated ROS production

(2020) Yafeng Sun et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer

(2020) Bo Zhang et al.   Molecular Cancer

Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis

(2020) Yan Liu et al.   MEDICAL SCIENCE MONITOR

Expression of SCD and FADS2 Is Lower in the Necrotic Core and Growing Tumor Area than in the Peritumoral Area of Glioblastoma Multiforme

(2020) Jan Korbecki et al.   Biomolecules

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

(2020) Han-jie Liu et al.   Frontiers in Cell and Developmental Biology

Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients

(2020) Zihao Wang et al.   Aging-US

The Application of Ferroptosis in Diseases

(2020) Yangmin Qiu et al.   PHARMACOLOGICAL RESEARCH

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

Targeting Ferroptosis to Iron Out Cancer

(2019) Behrouz Hassannia et al.   CANCER CELL

Molecular mechanisms of ferroptosis and its role in cancer therapy

(2019) Tao Xu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Immune checkpoints in the tumor microenvironment

(2019) Salman M. Toor et al.   SEMINARS IN CANCER BIOLOGY

m6A mRNA methylation sustains Treg suppressive functions

(2018) Jiyu Tong et al.   CELL RESEARCH

WHO 2016 Classification of gliomas

(2018) P. Wesseling et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

(2018) Diana Miao et al.   SCIENCE

The Development of the Concept of Ferroptosis

(2018) Tal Hirschhorn et al.   FREE RADICAL BIOLOGY AND MEDICINE

miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells

(2018) Fengfei Lu et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

(2018) Margriet IJzerman-Korevaar et al.   JOURNAL OF NEURO-ONCOLOGY

A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs

(2018) Manjari Kiran et al.   MOLECULAR NEUROBIOLOGY

Low-Grade Glioma Radiotherapy Treatment and Trials

(2018) Tony J.C. Wang et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Pediatric high-grade glioma: current molecular landscape and therapeutic approaches

(2017) Steve Braunstein et al.   JOURNAL OF NEURO-ONCOLOGY

Elements of cancer immunity and the cancer–immune set point

(2017) Daniel S. Chen et al.   NATURE

Glioma Subclassifications and Their Clinical Significance

(2017) Ricky Chen et al.   Neurotherapeutics

Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas

(2017) Desheng Xiao et al.   Theranostics

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

(2016) Willy Hugo et al.   CELL

Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness

(2016) Liping Liu et al.   MOLECULAR AND CELLULAR BIOLOGY

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas

(2015) Ricky Chen et al.   Neurosurgical Focus

The epidemiology of glioma in adults: a "state of the science" review

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Low-Grade Gliomas

(2014) D. A. Forst et al.   ONCOLOGIST

Radioimmunotherapy for high-grade glioma

(2013) Pasquale De Bonis et al.   Immunotherapy

Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival

(2011) Nicola VL Serão et al.   BMC Medical Genomics

Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas

(2009) Kaisorn L. Chaichana et al.   JOURNAL OF NEUROSURGERY